Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Sid P. Kerkar"'
Autor:
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo, Sid P. Kerkar, Mary Ann Toomey, Steven A. Feldman, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Richard M. Sherry, Lien T. Ngo, Azam V. Nahvi, Sadik H. Kassim, Mark E. Dudley, Zhili Zheng, Joal D. Beane, Richard A. Morgan, Ling Zhang
Supplemental figure 2. Phenotype of NFAT.IL12 gene modified TIL compared to matched untransduced TIL.Shown are the percentage of cells with a phenotype consistent with effector memory (CD62L-CD45RA-),central memory (CD62L+CD45RA-), Naive (CD62+, CD45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b62ad53dd29f0fe028259344ccc6ef
https://doi.org/10.1158/1078-0432.22457129.v1
https://doi.org/10.1158/1078-0432.22457129.v1
Autor:
Nicholas P. Restifo, Steven A. Rosenberg, Steven E. Finkelstein, Christopher D. Scott, Sid P. Kerkar, Zachary A. Borman, Christian S. Hinrichs, Yun Ji, Pawel Muranski, Douglas C. Palmer, Luca Gattinoni, Christopher A. Klebanoff
PDF file - 51K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25cbc7ee29f5351326a23eb09bb14e68
https://doi.org/10.1158/1078-0432.22442174
https://doi.org/10.1158/1078-0432.22442174
Autor:
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo, Sid P. Kerkar, Mary Ann Toomey, Steven A. Feldman, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Richard M. Sherry, Lien T. Ngo, Azam V. Nahvi, Sadik H. Kassim, Mark E. Dudley, Zhili Zheng, Joal D. Beane, Richard A. Morgan, Ling Zhang
Supplemental figure 4. IL6 and IL10 levels. Shown are data from five patients with elevated IL12 and IFNg levels that were subject to cytokine multiplex analysis. Only cytokine IL6 and IL10 were shown to be consistently elevated post-infusion.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e695baf815b4bc7224d3617847ff746
https://doi.org/10.1158/1078-0432.22457123.v1
https://doi.org/10.1158/1078-0432.22457123.v1
Autor:
Nicholas P. Restifo, Steven A. Rosenberg, Steven E. Finkelstein, Christopher D. Scott, Sid P. Kerkar, Zachary A. Borman, Christian S. Hinrichs, Yun Ji, Pawel Muranski, Douglas C. Palmer, Luca Gattinoni, Christopher A. Klebanoff
PDF file - 57K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4438606f3f5fe457288e64cc2549c223
https://doi.org/10.1158/1078-0432.22442171.v1
https://doi.org/10.1158/1078-0432.22442171.v1
Autor:
Steven A. Rosenberg, Nicholas P. Restifo, Richard A. Morgan, Ling Zhang, Sid P. Kerkar, Zhiya Yu, Dhanalakshmi Chinnasamy
Purpose: We investigated the feasibility of delivering the proinflammatory cytokine interleukin (IL)-12 into tumor using T cells genetically engineered to express a chimeric antigen receptor (CAR) against the VEGF receptor-2 (VEGFR-2).Experimental De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1591a415448bca7356f722b851d8b554
https://doi.org/10.1158/1078-0432.c.6520341
https://doi.org/10.1158/1078-0432.c.6520341
Autor:
Nicholas P. Restifo, Steven A. Rosenberg, Steven E. Finkelstein, Christopher D. Scott, Sid P. Kerkar, Zachary A. Borman, Christian S. Hinrichs, Yun Ji, Pawel Muranski, Douglas C. Palmer, Luca Gattinoni, Christopher A. Klebanoff
Purpose: Adoptive cell transfer (ACT) of tumor infiltrating or genetically engineered T cells can cause durable responses in patients with metastatic cancer. Multiple clinically modifiable parameters can comprise this therapy, including cell dose and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054eda6fd113ebbc8981e96138ffe50a
https://doi.org/10.1158/1078-0432.c.6518981.v1
https://doi.org/10.1158/1078-0432.c.6518981.v1
Autor:
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo, Sid P. Kerkar, Mary Ann Toomey, Steven A. Feldman, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Richard M. Sherry, Lien T. Ngo, Azam V. Nahvi, Sadik H. Kassim, Mark E. Dudley, Zhili Zheng, Joal D. Beane, Richard A. Morgan, Ling Zhang
supplemental figure legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d52a157271b8a79321afb83b58df0d
https://doi.org/10.1158/1078-0432.22457117
https://doi.org/10.1158/1078-0432.22457117
Autor:
Steven A. Rosenberg, Nicholas P. Restifo, Richard A. Morgan, Ling Zhang, Sid P. Kerkar, Zhiya Yu, Dhanalakshmi Chinnasamy
PDF file - 66K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f5af855d87dfadb10189a9a2995eeb
https://doi.org/10.1158/1078-0432.22444944.v1
https://doi.org/10.1158/1078-0432.22444944.v1
Autor:
Steven A. Rosenberg, Nicholas P. Restifo, Richard A. Morgan, Ling Zhang, Sid P. Kerkar, Zhiya Yu, Dhanalakshmi Chinnasamy
PDF file - 365K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60c2d428677987d698c8868e712d143b
https://doi.org/10.1158/1078-0432.22444947
https://doi.org/10.1158/1078-0432.22444947
Autor:
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo, Sid P. Kerkar, Mary Ann Toomey, Steven A. Feldman, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Richard M. Sherry, Lien T. Ngo, Azam V. Nahvi, Sadik H. Kassim, Mark E. Dudley, Zhili Zheng, Joal D. Beane, Richard A. Morgan, Ling Zhang
Supplemental figure 5. Treg reconstitution. Shown are the percentages of circulating T cells with a phenotype consistent with a Treg cell (CD4+/CD25+/FoxP3+). Data from parallel TIL trial using TIL administration but without exogenous IL2 support (TI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b749df4850268d6b252d83408150c20
https://doi.org/10.1158/1078-0432.22457120.v1
https://doi.org/10.1158/1078-0432.22457120.v1